Shanghai C&D Innostic Medical Technology Group Co., Ltd. logo

Shanghai C&D Innostic Medical Technology Group Co., Ltd. (301584)

Market Closed
11 Aug, 06:56
XSHE XSHE
¥
23. 35
-0.25
-1.0593%
¥
9.83B Market Cap
- P/E Ratio
0.2% Div Yield
9.96M Volume
- Eps
¥ 23.6
Previous Close
Add Transaction
Day Range
23.3 24.2
Year Range
7.05 46.2
Want to track 301584 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Shanghai C&D Innostic Medical Technology Group Co., Ltd. (301584) Statistics

Valuation metrics

Market Cap 9.83B
Enterprise value 10.5B
Trailing P/E (ttm) 31.92
Forward P/E -
PEG ratio 3.49
Price/Sales (ttm) 0.5
Price/Book (mrq) 3.94
Enterprise Value/Revenue 0.54
Enterprise Value/EBITDA 15.2

Overview

Shares outstanding 421.29M
Float 147.52M
Shares short -
% Held by insiders 0.87%
% Held by institutions 0.02%
Average volume (10 days) 2.21M
Average volume (90 days) 2.94M

Price summary

52-Week low 7.05
52-Week high 46.2
Beta -
50-Day moving average 27.04
200-Day moving average 29.96

Dividends and splits

Forward annual dividend rate 0.2
Forward annual dividend yield 0.0087%
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 8 Jun 2026
Ex-Dividend Date 1 Jun 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.02%
Operating margin 0.04%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.11%

Income Statement

Revenue (ttm) 19.3B
Revenue per share (ttm) 54.22
Quarterly revenue growth (yoy) 0.07%
Gross profit (ttm) 1.5B
EBITDA 783.89M
Net income to common (ttm) 299.65M
Diluted EPS (ttm) 0.72
Quarterly earnings growth (yoy) 0.49%

Balance Sheet

Total cash (mrq) 1.95B
Total cash per share (mrq) 5.48
Total debt (mrq) 3.92B
Total Debt/Equity (mrq) 161.95
Current ratio (mrq) 1.17%
Book value per share (mrq) 5.83

Cash Flow

Cash flow statement 1.31B
Levered free cash flow (LFCF) 269.63M